International Business Times
May 19, 2013
A 53-year-old British father has become the first man to have his prostate removed because tests revealed he was carrying a “faulty” cancer gene.
A clinical trial at London’s Institute of Cancer Research revealed that he carried the BRCA2 gene, which research shows is associated with a high risk of developing prostate cancer.
Several of the man’s family had suffered from breast or prostate cancer, which is why he took part in the study.